The following baseline data of all the participants were collected: gender, age, height, weight, and the duration of the disease. Hoehn & Yahr (H-Y) stage and UPDRS were used to assess the motor symptoms. To assess the non-motor symptoms, we used the Non-motor symptoms Scale (NMSS). Parkinson's Disease Sleep Scale (PDSS) and Pittsburgh sleep quality index (PSQI) were applied to evaluate the patients' sleep quality. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) and Mini-mental State Examination (MMSE). The quality of life was evaluated using the Parkinson's Disease Questionnaire-39 (PDQ39). Severity of anxiety and depression were quantified by the Hamilton Depression Scale (HAMD) and Hamilton Anxiety Scale (HAMA), respectively.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.